A Complete Ranking of the Best Frozen Pizzas

Right now in your freezer, you probably have a frozen pizza or two tucked away. Hey, we don’t blame you — since we’re all practicing social distancing due to the COVID-19 outbreak, we and many others do too. Why? Because it’s delicious! Not to mention it’s probably the easiest, quickest dinner option for all of

Doctors reverse jumping vision caused by light deprivation

Gradual exposure to light restored vision to a migraine sufferer who developed miner’s nystagmus after an extended period of severe light deprivation, reports a team led by UCL experts. Nystagmus is characterized by involuntary eye movements causing jumping and blurred vision, and is sometimes known as wobbly eyes or jerky eyes. Miner’s nystagmus is a

UK’s top 100 digital health innovators given a global boost

Major health tech bodies have collaborated on a global campaign to showcase the talents of 100 of the UK’s most innovative and impactful digital health innovators. The First 100 list features UK companies with a proven track record of benefiting the lives of healthcare professionals and patients in the NHS and private health sector. They include companies

Researchers explore suicide risk management protocol in cardiac patients

What should researchers do if they encounter a study participant who reports suicidal thoughts? UIC College of Nursing associate professor Susan Dunn explores this question as lead author of "Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness," a paper published in the January/February edition of Nursing Research. Suicide is

Tiger Woods Hospitalized After Wreck in Los Angeles

Professional golfer Tiger Woods has multiple injuries to his legs after a Tuesday morning one-vehicle wreck in Los Angeles, his agent, Mark Steinberg, told Golf Digest. Tiger Woods AP “He is currently in surgery,” Steinberg said, “and we thank you for your privacy and support.” Woods, 45, was the only occupant of a vehicle involved

From Gum to Gummies, Beau Wrigley Takes Pot Producer Parallel Public

(Reuters) – Billionaire William “Beau” Wrigley Jr is taking cannabis producer Parallel public, in a merger due to complete this summer with Canadian-listed Ceres Acquisition Corp that values the Atlanta, Georgia-based firm at $1.88 billion. Parallel, the first firm Wrigley Jr has led since selling his family’s chewing gum business for $23 billion in 2008,

Study finds disadvantaged census tracts linked to COVID-19 incidence

An LSU Health New Orleans School of Public Health study reports a positive association between social vulnerability and COVID-19 incidence at the census tract level and recommends that more resources be allocated to socially vulnerable populations to reduce the incidence of COVID-19. The findings are published in Frontiers in Public Health, available here. “In our

Why some ‘super ager’ folks keep their minds dementia-free

(HealthDay)—Researchers may have uncovered a key reason some people remain sharp as a tack into their 80s and 90s: Their brains resist the buildup of certain proteins that mark Alzheimer’s disease. The study focused on what scientists have dubbed “super agers”—a select group of older folks who have the memory performance of people decades younger.

How effective has Israel’s SARS-CoV-2 testing and vaccination campaign been against the UK variant?

Several genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have risen to prominence during the course of the coronavirus disease 2019 (COVID-19) pandemic, one of which is the UK variant – termed B.1.1.7 by the Centers for Disease Control and Prevention (CDC). This variant is associated with increased transmissibility compared to the wild-type

Americans less worried about dying from COVID-19 as support for vaccine mandate grows

In a new ongoing panel survey by Northwestern University and The Ohio State University, researchers find Americans significantly less concerned they could die of COVID-19, while their overall perceived likelihood of contracting the virus remained relatively consistent from December through February. “Public Attitudes about COVID-19 Vaccination,” a study of 1,200 Americans surveyed monthly from December

Not to be sniffed at: Agony of post-COVID-19 loss of smell

The doctor slid a miniature camera into the patient’s right nostril, making her whole nose glow red with its bright miniature light. “Tickles a bit, eh?” he asked as he rummaged around her nasal passages, the discomfort causing tears to well in her eyes and roll down her cheeks. The patient, Gabriella Forgione, wasn’t complaining.

Current monoclonal antibodies less potent against SARS-CoV-2 variants

The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to wreak havoc across the globe. Scientists are racing to develop effective therapeutic regimens to combat the infection. One of therapy currently used to stimulate a robust immune response against the virus is monoclonal antibodies, a treatment used for